Silexion Therapeutics (SLXN) Operating Leases (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Operating Leases of $251000.0 for Q1 2026, down 24.85% year-over-year from $334000.0 in Q1 2025, and down 12.24% quarter-over-quarter from $286000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Operating Leases (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $251000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 24.85% year-over-year to $251000.0; the TTM figure through Mar 2026 stood at $251000.0 (down 24.85% YoY), while the FY2025 annual figure was $286000.0, down 22.28% from the prior year.
- Operating Leases for Q1 2026 stood at $251000.0, down from $286000.0 in the prior quarter.
- The five-year high for Operating Leases was $368000.0 in Q4 2024, with the low at $8000.0 in Q2 2024.
- The 4-year median for Operating Leases is $298500.0 (2025), against an average of $258250.0.
- The sharpest annual moves came in 2025 and 2026: Operating Leases jumped 4112.5% in 2025, then retreated 24.85% in 2026.
- Silexion Therapeutics' Operating Leases stood at $171000.0 in 2023, then jumped by 115.2% to $368000.0 in 2024, then slipped by 22.28% to $286000.0 in 2025, then dropped by 12.24% to $251000.0 in 2026.
- Business Quant data shows SLXN's Operating Leases at $251000.0 in Q1 2026, $286000.0 in Q4 2025, and $311000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 226,000.00 |
| Mar 31, 2026 | 251,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 311,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Mar 31, 2025 | 334,000.00 |
| Dec 31, 2024 | 368,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Dec 31, 2023 | 171,000.00 |